$OXYS has been accelerating its penetration in the marketplace, reporting fourteen consecutive quarters of top line growth, including record revenues in 3Q15. We see several catalysts ahead for the company as it heads in to 2016E seeking to uplist to a national exchange and aspiring to reach $10mn in annualized sales and cash flow breakeven.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.